Stemness and the cellular response to virus infection
干性和细胞对病毒感染的反应
基本信息
- 批准号:9528170
- 负责人:
- 金额:$ 26.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-01-03 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:Antiviral AgentsAntiviral ResponseBackBiologicalBiological ModelsBiologyCell Differentiation processCellsCellular biologyDataEffectivenessEmbryoEndogenous RetrovirusesEngineeringExhibitsFibroblastsFutureGene Expression ProfileGenerationsGeneticGenetic TranscriptionGenomeHandHumanHuman BiologyImmuneInfectionInfluenza A virusInterferon Type IInterferon-alphaInterferonsKnowledgeLifeMaintenanceModelingMolecularMusNatureOrganismPhenotypePhysiologicalPopulationProcessPropertyProteomicsRNA InterferenceRNA VirusesRefractoryRegenerative MedicineReporterReserve CellResistanceResistance to infectionRoleShapesStem cellsStomatitisSystemTestingTherapeuticTimeTreesVesicular stomatitis Indiana virusViralVirusVirus DiseasesVirus ReplicationWorkarmbasecombatdesignembryonic stem cellin vivoin vivo Modelinduced pluripotent stem cellpathogenpenis foreskinpressureprogenitorrepairedresponseself-renewalstemstem cell biologystemnesssuccesstheoriestissue repairtooltranscriptomicsvirtualvirus pathogenesis
项目摘要
PROJECT SUMMARY
Given the virtually infinite niches and time to expand, every evolutionary scenario possible has had a hand in
shaping what we see today, perhaps independently many times and in many places. Arguably, one of the most
powerful drivers of this evolutionary life process is the struggle between virus and host that has resulted in very
diverse defensive strategies. Interestingly, while the cellular response to virus infection was thought to be
uniform in any one given species, evidence is mounting that mammalian stem cells have a unique strategy to
combat virus that is distinct from all other cells of the body. This observation is largely based on the finding
that these cells can successfully block productive virus infection, despite lacking the capacity to produce or
respond to Type I interferon. In this exploratory R21, we seek to ascertain the molecular basis for this activity.
To this end, we focus on an ex vivo model using primary fibroblasts and reprogrammed induced pluripotent
stem (iPS) cells in Aim 1 as well as an in vivo model to identify and characterize resident stem cells during a
productive virus infection in Aim 2.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Benjamin R. tenOever其他文献
RNA viruses and the host microRNA machinery
RNA 病毒与宿主微小 RNA 机制
- DOI:
10.1038/nrmicro2971 - 发表时间:
2013-02-15 - 期刊:
- 影响因子:103.300
- 作者:
Benjamin R. tenOever - 通讯作者:
Benjamin R. tenOever
Benjamin R. tenOever的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Benjamin R. tenOever', 18)}}的其他基金
Defining the Biology of the ADAR1-RISC Complex
定义 ADAR1-RISC 复合体的生物学
- 批准号:
10879449 - 财政年份:2022
- 资助金额:
$ 26.84万 - 项目类别:
Defining the Biology of the ADAR1-RISC Complex
定义 ADAR1-RISC 复合体的生物学
- 批准号:
10494390 - 财政年份:2022
- 资助金额:
$ 26.84万 - 项目类别:
Characterizing a transcriptional control region within the Type I interferon gene cluster
表征 I 型干扰素基因簇内的转录控制区域
- 批准号:
10624947 - 财政年份:2022
- 资助金额:
$ 26.84万 - 项目类别:
Characterizing a transcriptional control region within the Type I interferon gene cluster
表征 I 型干扰素基因簇内的转录控制区域
- 批准号:
10506860 - 财政年份:2022
- 资助金额:
$ 26.84万 - 项目类别:
Defining the Biology of the ADAR1-RISC Complex
定义 ADAR1-RISC 复合体的生物学
- 批准号:
10631184 - 财政年份:2022
- 资助金额:
$ 26.84万 - 项目类别:
Small viral RNAs as determinants of influenza A virus pathogenesis
小病毒 RNA 作为甲型流感病毒发病机制的决定因素
- 批准号:
10557136 - 财政年份:2020
- 资助金额:
$ 26.84万 - 项目类别:
Small viral RNAs as determinants of influenza A virus pathogenesis
小病毒 RNA 作为甲型流感病毒发病机制的决定因素
- 批准号:
10524881 - 财政年份:2020
- 资助金额:
$ 26.84万 - 项目类别:
Small viral RNAs as determinants of influenza A virus pathogenesis
小病毒 RNA 作为甲型流感病毒发病机制的决定因素
- 批准号:
10097984 - 财政年份:2020
- 资助金额:
$ 26.84万 - 项目类别:
The biology of the nuclear export protein in influenza A virus replication
甲型流感病毒复制中核输出蛋白的生物学
- 批准号:
9975684 - 财政年份:2017
- 资助金额:
$ 26.84万 - 项目类别:
The mammalian small RNA machinery and its role in antiviral defenses
哺乳动物小RNA机制及其在抗病毒防御中的作用
- 批准号:
8967559 - 财政年份:2014
- 资助金额:
$ 26.84万 - 项目类别:
相似海外基金
Regulation of RIG-I mediated antiviral response upon influenza A virus infection
RIG-I介导的甲型流感病毒感染抗病毒反应的调节
- 批准号:
494286 - 财政年份:2023
- 资助金额:
$ 26.84万 - 项目类别:
Operating Grants
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
激活 DNA-PK 依赖性抗病毒反应作为一种新型癌症免疫疗法
- 批准号:
10364056 - 财政年份:2022
- 资助金额:
$ 26.84万 - 项目类别:
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
- 批准号:
10621913 - 财政年份:2022
- 资助金额:
$ 26.84万 - 项目类别:
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
- 批准号:
10373627 - 财政年份:2022
- 资助金额:
$ 26.84万 - 项目类别:
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
激活 DNA-PK 依赖性抗病毒反应作为一种新型癌症免疫疗法
- 批准号:
10553146 - 财政年份:2022
- 资助金额:
$ 26.84万 - 项目类别:
Mechanisms of IgE-mediated regulation of monocyte antiviral response pathways
IgE介导的单核细胞抗病毒反应途径的调节机制
- 批准号:
10640247 - 财政年份:2021
- 资助金额:
$ 26.84万 - 项目类别:
Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection
AMPK 和 Hippo 信号传导之间的相互作用调节眼部对寨卡病毒感染的抗病毒反应
- 批准号:
10322026 - 财政年份:2021
- 资助金额:
$ 26.84万 - 项目类别:
Mechanisms of IgE-mediated regulation of monocyte antiviral response pathways
IgE 介导的单核细胞抗病毒反应途径调节机制
- 批准号:
10438876 - 财政年份:2021
- 资助金额:
$ 26.84万 - 项目类别:
Antiviral response coupled with transposon derepression in Alzheimer's disease and aging
抗病毒反应与转座子去抑制在阿尔茨海默病和衰老中的作用
- 批准号:
10629440 - 财政年份:2021
- 资助金额:
$ 26.84万 - 项目类别:
Epigenetic Control of Mucosal IRF1/IFN-III Antiviral Response by Enhancer-like Promoter and its Coding lncRNA
增强子样启动子及其编码lncRNA对粘膜IRF1/IFN-III抗病毒反应的表观遗传控制
- 批准号:
10373575 - 财政年份:2021
- 资助金额:
$ 26.84万 - 项目类别:














{{item.name}}会员




